Duchenne Muscular Dystrophy (dmd) Treatment Market Size Share Analysis 2022
December 31, 2022 ⚊ 1 Min read ⚊ Views 83 ⚊ BUSINESSDuchenne muscular dystrophy is one of the nine kinds of muscular dystrophy. It is a genetic disorder characterized by progressive degeneration and weakness of muscle. The onset of symptoms will be from early childhood in the age of 3-5. It is caused because of the absence of dystrophin protein, which assists to keep muscle cells intact. No known cure is there for duchenne muscular dystrophy however the treatment is given to control the symptoms for maximizing the quality of life of the patient. A few products are there marketed to treat duchenne muscular dystrophy-like Emflaza, Translama and Exodus 51.
Tags: Duchenne Muscular Dystrophy (DMD) Treatment Market